Find Grants for School Districts
Find out if you qualify for verified grants for School Districts. Discover your eligibility and key funding details for School Districts from major foundations and government agencies.
Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-039
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-040
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
Deadline: September 7, 2026
Opportunity Number: PAR-25-095
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.121, 93.866, 93.393, 93.172
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
Deadline: September 7, 2026
Opportunity Number: PAR-25-096
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.121, 93.866, 93.172, 93.393
Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
Deadline: March 16, 2026
Opportunity Number: PA-25-246
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: March 16, 2026
Status: Posted
CFDA Numbers: 93.866
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-067
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
Deadline: September 7, 2026
Opportunity Number: PAR-25-066
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: September 7, 2026
Status: Posted
CFDA Numbers: 93.242
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
Deadline: May 7, 2026
Opportunity Number: PAR-25-110
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.855, 93.279, 93.313, 93.242, 93.865
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Deadline: May 7, 2026
Opportunity Number: PAR-25-111
Agency: National Institutes of Health
Open Date: November 18, 2024
Close Date: May 7, 2026
Status: Posted
CFDA Numbers: 93.865, 93.855, 93.279, 93.313
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)
Deadline: February 8, 2027
Opportunity Number: RFA-MH-26-170
Agency: National Institutes of Health
Open Date: November 15, 2024
Close Date: February 8, 2027
Status: Posted
CFDA Numbers: 93.273, 93.213, 93.866, 93.867, 93.242, 93.286, 93.853, 93.865, 93.173, 93.279
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
Deadline: November 5, 2026
Opportunity Number: PAR-25-255
Agency: National Institutes of Health
Open Date: November 15, 2024
Close Date: November 5, 2026
Status: Posted
CFDA Numbers: 93.399, 93.242, 93.172
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2027
Opportunity Number: PAR-25-256
Agency: National Institutes of Health
Open Date: November 15, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.399, 93.172
Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-273
Agency: National Institutes of Health
Open Date: November 15, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.351
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)
Deadline: May 4, 2028
Opportunity Number: PA-25-168
Agency: National Institutes of Health
Open Date: November 15, 2024
Close Date: May 4, 2028
Status: Posted
CFDA Numbers: 93.273, 93.865, 93.279, 93.172, 93.313, 93.351, 93.867, 93.310, 93.846, 93.838, 93.847, 93.113, 93.853, 93.397, 93.855, 93.213, 93.361, 93.286, 93.233, 93.242, 93.840, 93.399, 93.398, 93.837, 93.173, 93.121, 93.839, 93.866, 93.396, 93.859
Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)
Deadline: March 5, 2026
Opportunity Number: PAR-25-209
Agency: National Institutes of Health
Open Date: November 14, 2024
Close Date: March 5, 2026
Status: Posted
CFDA Numbers: 93.866
Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)
Deadline: April 20, 2027
Opportunity Number: RFA-ES-25-002
Agency: National Institutes of Health
Open Date: November 14, 2024
Close Date: April 20, 2027
Status: Posted
CFDA Numbers: 93.113
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-203
Agency: National Institutes of Health
Open Date: November 14, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.859
Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-202
Agency: National Institutes of Health
Open Date: November 14, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.859
Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)
Deadline: June 22, 2026
Opportunity Number: PAR-25-170
Agency: National Institutes of Health
Open Date: November 13, 2024
Close Date: June 22, 2026
Status: Posted
CFDA Numbers: 93.399, 93.853, 93.866
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-167
Agency: National Institutes of Health
Open Date: November 12, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.399, 93.393
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
Deadline: September 7, 2028
Opportunity Number: PA-25-253
Agency: National Institutes of Health
Open Date: November 12, 2024
Close Date: September 7, 2028
Status: Posted
CFDA Numbers: 93.399, 93.393
NIDCR Dentist Scientist Career Transition Award for Intramural Investigators (K22 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-027
Agency: National Institutes of Health
Open Date: November 12, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.121
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
Deadline: January 7, 2027
Opportunity Number: PAR-25-081
Agency: National Institutes of Health
Open Date: November 12, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.393, 93.399, 93.394, 93.395
Laboratories to Optimize Digital Health (R01 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PAR-25-136
Agency: National Institutes of Health
Open Date: November 7, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PA-25-172
Agency: National Institutes of Health
Open Date: November 7, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.399, 93.393
